Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.95 USD -2.92%
Market Cap: 1.5B USD
Have any thoughts about
Arcus Biosciences Inc?
Write Note

Arcus Biosciences Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
Accounts Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Accounts Receivables
$21m
CAGR 3-Years
89%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Receivables
$11.5B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Receivables
$4.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Accounts Receivables
$7.3B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Receivables
$1.8B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Receivables
$6.1B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Arcus Biosciences Inc's Accounts Receivables?
Accounts Receivables
21m USD

Based on the financial report for Sep 30, 2024, Arcus Biosciences Inc's Accounts Receivables amounts to 21m USD.

What is Arcus Biosciences Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
32%

Over the last year, the Accounts Receivables growth was -63%. The average annual Accounts Receivables growth rates for Arcus Biosciences Inc have been 89% over the past three years , 32% over the past five years .

Back to Top